Skip to content

Clinical trials

Uterine Cervical Neoplasms trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Country / region: Mexico Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20062
20071
20082
20101
20121
20132
20152
20172
20184
20193
20202
20211
20222
20231
20243
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status6
Recruiting5
Active, not recruiting3
Terminated3
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Cancerología14
Merck Sharp & Dohme LLC3
GlaxoSmithKline2
Hoffmann-La Roche2
Instituto Nacional de Salud Publica, Mexico2
Timser SAPI de CV2
Agenus Inc.1
Amgen1
Daiichi Sankyo1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms35
Neoplasms4
Recurrence3
Atypical Squamous Cells of the Cervix2
Colorectal Neoplasms2
Papillomavirus Infections2
Radiation Injuries2
Squamous Cell Carcinoma of Head and Neck2
Uterine Cervical Dysplasia2
Adenocarcinoma1

Trials

Showing 51 to 35 of 35. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.